Statistics
Publications
24
Citations
4.5K
H-Index
19
Active since
1997
Jeremy Travins is an author at Agios Pharmaceuticals (United States) specializing in medicine, pharmacology, and molecular oncology.
Publications per year
1997–2022
24
24
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang, Jeremy Travins, Byron DeLaBarre et al. · Science · 2013 · 797 citations
Medicine, Cancer Biology, Oncology +10
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen, Sung-Woo Lee, Christopher G. Duncan et al. · Nature · 2012 · 722 citations · Full text
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Katya Marjon, Michael J. Cameron, Phong Quang et al. · Cell Reports · 2016 · 447 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 24